Histological variants of medulloblastoma are the most powerful clinical prognostic indicators
Pediatric Blood & Cancer, 06/22/2012
Massimino M et al. – Tailoring treatments to known risk factors cancelled all prognostic differences, except for anaplasia (not considered as such within previous trials) which proved the most powerful prognostic factor, warranting appropriate treatment intensification.



